Do the claim limits for High-Cost Drugs (HCD) and Cell, Tissue and Gene Therapy Products (CTGTP) apply if these treatments are administered during an inpatient stay or day surgery?
Yes, if a patient receives High-Cost Drugs (HCD) or Cell, Tissue and Gene Therapy Products (CTGTP) treatment during an inpatient or day surgery admission, the respective HCD/CTGTP claim limit will apply to these treatments, while the daily inpatient hospital limit will apply to the room and board charges. This ensures adequate healthcare financing support by MediShield Life and MediSave for patients who receive HCD or CTGTP treatment in inpatient or day surgery settings.

Was this article helpful?